Helicobacter pylori (H. pylori) is a widespread bacterial infection associated with gastritis, peptic ulcers, and gastric cancer. While conventional antibiotic-based treatments have been the gold standard for eradication, their efficacy has been steadily declining due to the alarming rise in antibiotic resistance. This has spurred interest in alternative therapies, one of which is fecal microbiota transplantation (FMT).
FMT is a novel therapeutic approach that involves transferring microbiota from a healthy donor to a patient’s gastrointestinal tract. This process aims to restore microbial balance and has shown promise in treating various gastrointestinal disorders, particularly Clostridioides difficile infections. Recent research suggests that FMT could play a pivotal role in the eradication of H….